{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:24:25Z","timestamp":1792859065138,"version":"4.5.0"},"reference-count":135,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Malignant melanoma (MM) is the most common and deadliest type of skin cancer and is associated with high mortality rates across all races and ethnicities. Although present treatment options combined with surgery provide short-term clinical benefit in patients and early diagnosis of non-metastatic MM significantly increases the probability of survival, no efficacious treatments are available for MM. The etiology and pathogenesis of MM are complex. Acquired drug resistance is associated with a pool prognosis in patients with advanced-stage MM. Thus, these patients require new therapeutic strategies to improve their treatment response and prognosis. Multiple studies have revealed that ferroptosis, a non-apoptotic form of regulated cell death (RCD) characterized by iron dependant lipid peroxidation, can prevent the development of MM. Recent studies have indicated that targeting ferroptosis is a promising treatment strategy for MM. This review article summarizes the core mechanisms underlying the development of ferroptosis in MM cells and its potential role as a therapeutic target in MM. We emphasize the emerging types of small molecules inducing ferroptosis pathways by boosting the antitumor activity of BRAFi and immunotherapy and uncover their beneficial effects to treat MM. We also summarize the application of nanosensitizer-mediated unique dynamic therapeutic strategies and ferroptosis-based nanodrug targeting strategies as therapeutic options for MM. This review suggests that pharmacological induction of ferroptosis may be a potential therapeutic target for MM.<\/jats:p>","DOI":"10.3389\/fphar.2023.1252567","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T04:34:43Z","timestamp":1695184483000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Ferroptosis as a promising therapeutic strategy for melanoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Na","family":"Ta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1365-2230.1989.tb02602.x","article-title":"Cutaneous and ocular side-effects of PUVA photochemotherapy-a 10-year follow-up study","volume":"14","author":"Abdullah","year":"1989","journal-title":"Clin. Exp. Dermatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.molmed.2014.12.007","article-title":"Molecular drivers of cellular metabolic reprogramming in melanoma","volume":"21","author":"Abildgaard","year":"2015","journal-title":"Trends Mol. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1972516","DOI":"10.1155\/2022\/1972516","article-title":"lncRNA AGAP2-AS1 facilitates tumorigenesis and ferroptosis resistance through SLC7A11 by IGF2BP2 pathway in melanoma","volume":"2022","author":"An","year":"2022","journal-title":"Comput. Math. Methods Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"108301","DOI":"10.1016\/j.pharmthera.2022.108301","article-title":"Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises","volume":"240","author":"Anestopoulos","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e2716","DOI":"10.1038\/cddis.2017.133","article-title":"Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells","volume":"8","author":"Basit","year":"2017","journal-title":"Cell Death Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.hoc.2020.08.011","article-title":"Epidemiology of melanoma","volume":"35","author":"Bolick","year":"2021","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"B7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","article-title":"The great escape: Tumour cell plasticity in resistance to targeted therapy","volume":"19","author":"Boumahdi","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"B8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1039\/d1sc05482a","article-title":"Recent advances of cancer chemodynamic therapy based on Fenton\/Fenton-like chemistry","volume":"13","author":"Cao","year":"2022","journal-title":"Chem. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.3390\/ijms24065698","article-title":"Cinnamomum zeylanicum blume essential oil inhibits metastatic melanoma cell proliferation by triggering an incomplete tumour cell stress response","volume":"24","author":"Cappelli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/ijms24021263","article-title":"Hyperforin elicits cytostatic\/cytotoxic activity in human melanoma cell lines, inhibiting pro-survival NF-\u03baB, STAT3, AP1 transcription factors and the expression of functional proteins involved in mitochondrial and cytosolic metabolism","volume":"24","author":"Cardile","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.suc.2019.09.005","article-title":"Epidemiology and risk factors of melanoma","volume":"100","author":"Carr","year":"2020","journal-title":"Surg. Clin. North Am."},{"key":"B12","doi-asserted-by":"publisher","first-page":"106148","DOI":"10.1016\/j.phrs.2022.106148","article-title":"Phyto-sesquiterpene lactones DET and DETD-35 induce ferroptosis in vemurafenib sensitive and resistant melanoma via GPX4 inhibition and metabolic reprogramming","volume":"178","author":"Chang","year":"2022","journal-title":"Pharmacol. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: The role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","article-title":"The chemical basis of ferroptosis","volume":"15","author":"Conrad","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/BF02303485","article-title":"Malignant melanoma of the mucous membranes: A review of 119 cases","volume":"5","author":"DeMatos","year":"1998","journal-title":"Ann. Surg. Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.molcel.2023.03.005","article-title":"Ferroptosis: A flexible constellation of related biochemical mechanisms","volume":"83","author":"Dixon","year":"2023","journal-title":"Mol. Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"10461","DOI":"10.1039\/d0tb02138e","article-title":"Bioactive metal-containing nanomaterials for ferroptotic cancer therapy","volume":"8","author":"Fei","year":"2020","journal-title":"J. Mater Chem. B"},{"key":"B21","doi-asserted-by":"publisher","first-page":"865073","DOI":"10.3389\/fgene.2022.865073","article-title":"Nobiletin induces ferroptosis in human skin melanoma cells through the gsk3\u03b2-mediated keap1\/nrf2\/HO-1 signalling pathway","volume":"13","author":"Feng","year":"2022","journal-title":"Front. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.3390\/molecules27133970","article-title":"Novel iron oxide nanoparticles induce ferroptosis in a panel of cancer cell lines","volume":"27","author":"Fern\u00e1ndez-Acosta","year":"2022","journal-title":"Molecules"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2020033","DOI":"10.5826\/dpc.1003a33","article-title":"Melanoma epidemiology and early detection in europe: Diversity and disparities","volume":"10","author":"Forsea","year":"2020","journal-title":"Dermatol Pract. Concept"},{"key":"B24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/life10090208","article-title":"Treatment of advanced melanoma: Past, present and future","volume":"10","author":"Fujimura","year":"2020","journal-title":"Life (Basel)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41419-019-2143-7","article-title":"Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis","volume":"10","author":"Gagliardi","year":"2019","journal-title":"Cell Death Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","article-title":"Lipid peroxidation in cell death","volume":"482","author":"Gaschler","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cmet.2018.09.002","article-title":"PML-regulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers","volume":"29","author":"Gentric","year":"2019","journal-title":"Cell Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1021\/acs.bioconjchem.1c00288","article-title":"Molecular imaging-guided sonodynamic therapy","volume":"33","author":"Guo","year":"","journal-title":"Bioconjug. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4143\/crt.2016.572","article-title":"Ferroptosis: A novel anti-tumor action for cisplatin","volume":"50","author":"Guo","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e004381","DOI":"10.1136\/jitc-2021-004381","article-title":"Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis","volume":"10","author":"Guo","year":"","journal-title":"J. Immunother. Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.stem.2018.11.011","article-title":"Phenotypic plasticity: Driver of cancer initiation, progression, and therapy resistance","volume":"24","author":"Gupta","year":"2019","journal-title":"Cell Stem Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2020.04.039","article-title":"SnapShot: Ferroptosis","volume":"181","author":"Hadian","year":"2020","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ccell.2019.12.007","article-title":"Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis","volume":"37","author":"Hanniford","year":"2020","journal-title":"Cancer Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","article-title":"Oncogenic BRAF regulates oxidative metabolism via PGC1\u03b1 and MITF","volume":"23","author":"Haq","year":"2013","journal-title":"Cancer Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2147\/IJN.S405020","article-title":"Research progress of nanomedicine-based mild photothermal therapy in tumor","volume":"18","author":"He","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1158\/2159-8290.CD-19-1500","article-title":"The lipogenic regulator SREBP2 induces transferrin in circulating melanoma cells and suppresses ferroptosis","volume":"11","author":"Hong","year":"2021","journal-title":"Cancer Discov."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.cell.2015.07.061","article-title":"Non-genomic and immune evolution of melanoma acquiring MAPKi resistance","volume":"162","author":"Hugo","year":"2015","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.1021\/acs.molpharmaceut.9b00737","article-title":"Ultrastable and biofunctionalizable conjugated polymer nanoparticles with encapsulated iron for ferroptosis assisted chemodynamic therapy","volume":"16","author":"Jasim","year":"2019","journal-title":"Mol. Pharm."},{"key":"B40","doi-asserted-by":"publisher","first-page":"121561","DOI":"10.1016\/j.biomaterials.2022.121561","article-title":"Nano-enabled photosynthesis in tumours to activate lipid peroxidation for overcoming cancer resistances","volume":"285","author":"Jiang","year":"2022","journal-title":"Biomaterials"},{"key":"B41","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/cancers15030585","article-title":"The current status of photodynamic therapy in cancer treatment","volume":"15","author":"Jiang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.3390\/ijms20194968","article-title":"Programmed cell-death by ferroptosis: Antioxidants as mitigators","volume":"20","author":"Kajarabille","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4081\/oncol.2017.326","article-title":"Chemotherapy resistance mechanisms in advanced skin cancer","volume":"11","author":"Kalal","year":"2017","journal-title":"Oncol. Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1089\/ars.2017.7176","article-title":"The roles of NRF2 in modulating cellular iron homeostasis","volume":"29","author":"Kerins","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"B46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41419-018-0340-4","article-title":"Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors","volume":"9","author":"Khamari","year":"2018","journal-title":"Cell Death Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12935-020-1100-y","article-title":"Anti-cancer effect of gallic acid in presence of low level laser irradiation: ROS production and induction of apoptosis and ferroptosis","volume":"20","author":"Khorsandi","year":"2020","journal-title":"Cancer Cell Int."},{"key":"B48","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nnano.2016.164","article-title":"Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth","volume":"11","author":"Kim","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/med.21935","article-title":"Photodynamic therapy: Innovative approaches for antibacterial and anticancer treatments","volume":"43","author":"Kolarikova","year":"2023","journal-title":"Med. Res. Rev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"6427","DOI":"10.2147\/IJN.S388996","article-title":"Combined photodynamic and photothermal therapy and immunotherapy for cancer treatment: A review","volume":"17","author":"Kong","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"B51","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s13238-021-00823-0","article-title":"Cytochrome P450 reductase (POR) as a ferroptosis fuel","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ncb3513","article-title":"The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer","volume":"19","author":"Krebs","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","article-title":"Linking EMT programmes to normal and neoplastic epithelial stem cells","volume":"21","author":"Lambert","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"B54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-Year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s13238-021-00841-y","article-title":"Ferroptosis, radiotherapy, and combination therapeutic strategies","volume":"12","author":"Lei","year":"2021","journal-title":"Protein Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1021\/acschembio.2c00113","article-title":"Targeting ErbB3 and cellular NADPH\/NADP(+) abundance sensitizes cutaneous melanomas to ferroptosis inducers","volume":"17","author":"Leu","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"113253","DOI":"10.1016\/j.colsurfb.2023.113253","article-title":"DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11\/GPX4-mediated ferroptosis","volume":"225","author":"Li","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B60","doi-asserted-by":"publisher","first-page":"042013","DOI":"10.1088\/1748-605X\/ac058a","article-title":"The potential application of nanomaterials for ferroptosis-based cancer therapy","volume":"16","author":"Li","year":"2021","journal-title":"Biomed. Mater"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e2203085","DOI":"10.1002\/adhm.202203085","article-title":"Ferroptosis: The entanglement between traditional drugs and nanodrugs in tumor therapy","volume":"12","author":"Liu","year":"","journal-title":"Adv. Healthc. Mater"},{"key":"B62","doi-asserted-by":"publisher","first-page":"rbad004","DOI":"10.1093\/rb\/rbad004","article-title":"Ferroptosis: Challenges and opportunities for nanomaterials in cancer therapy","volume":"10","author":"Liu","year":"","journal-title":"Regen. Biomater."},{"key":"B63","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3389\/fphar.2017.00992","article-title":"The role of ferroptosis in cancer development and treatment response","volume":"8","author":"Lu","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"9937","DOI":"10.7150\/thno.65480","article-title":"Targeting ferroptosis-based cancer therapy using nanomaterials: Strategies and applications","volume":"11","author":"Luo","year":"2021","journal-title":"Theranostics"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41418-017-0053-8","article-title":"miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma","volume":"25","author":"Luo","year":"2018","journal-title":"Cell Death Differ."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1039\/d2bm02000a","article-title":"Self-assembled nanomaterials for ferroptosis-based cancer theranostics","volume":"11","author":"Ma","year":"","journal-title":"Biomater. Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1039\/d2bm01126c","article-title":"Boosting cancer immunotherapy by biomineralized nanovaccine with ferroptosis-inducing and photothermal properties","volume":"11","author":"Ma","year":"","journal-title":"Biomater. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: A therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"153261","DOI":"10.1016\/j.phymed.2020.153261","article-title":"N-acetylglycoside of oleanolic acid (aridanin) displays promising cytotoxicity towards human and animal cancer cells, inducing apoptotic, ferroptotic and necroptotic cell death","volume":"76","author":"Mbaveng","year":"2020","journal-title":"Phytomedicine"},{"key":"B70","doi-asserted-by":"publisher","first-page":"100024","DOI":"10.1016\/j.lanepe.2021.100024","article-title":"Changing epidemiology and age-specific incidence of cutaneous malignant melanoma in England: An analysis of the national cancer registration data by age, gender and anatomical site, 1981-2018","volume":"2","author":"Memon","year":"2021","journal-title":"Lancet Reg. Health Eur."},{"key":"B71","first-page":"73","article-title":"99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection","volume":"48","author":"Miao","year":"2007","journal-title":"J. Nucl. Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1038\/ncomms6712","article-title":"Low MITF\/AXL ratio predicts early resistance to multiple targeted drugs in melanoma","volume":"5","author":"M\u00fcller","year":"2014","journal-title":"Nat. Commun."},{"key":"B73","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0887-8994(94)00155-u","article-title":"Primary malignant melanoma of meninges: Atypical presentation of subacute meningitis","volume":"12","author":"Nicolaides","year":"1995","journal-title":"Pediatr. Neurol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"215592","DOI":"10.1016\/j.canlet.2022.215592","article-title":"Sonodynamic therapy: Rapid progress and new opportunities for non-invasive tumor cell killing with sound","volume":"532","author":"Nowak","year":"2022","journal-title":"Cancer Lett."},{"key":"B75","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.1038\/s41598-022-09078-z","article-title":"AXL inhibition improves BRAF-targeted treatment in melanoma","volume":"12","author":"Nyakas","year":"2022","journal-title":"Sci. Rep."},{"key":"B76","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.3390\/ijms20174203","article-title":"Physiologically relevant oxygen concentration (6% O(2)) as an important component of the microenvironment impacting melanoma phenotype and melanoma response to targeted therapeutics in vitro","volume":"20","author":"Osrodek","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"188754","DOI":"10.1016\/j.bbcan.2022.188754","article-title":"Targeting EGFR in melanoma - the sea of possibilities to overcome drug resistance","volume":"1877","author":"Pastwi\u0144ska","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1158\/1078-0432.CCR-21-2138","article-title":"Molecular pathways and mechanisms of BRAF in cancer therapy","volume":"28","author":"Poulikakos","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.3390\/cancers12102801","article-title":"Mechanisms of acquired BRAF inhibitor resistance in melanoma: A systematic review","volume":"12","author":"Proietti","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B80","doi-asserted-by":"publisher","first-page":"104919","DOI":"10.1016\/j.phrs.2020.104919","article-title":"The application of ferroptosis in diseases","volume":"159","author":"Qiu","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2020.06.028","article-title":"Transcription factor NRF2 as a promising therapeutic target for Alzheimer's disease","volume":"159","author":"Qu","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41525-017-0013-8","article-title":"Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma","volume":"2","author":"Reuben","year":"2017","journal-title":"NPJ Genom Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/md19080459","article-title":"Bioactivity screening of antarctic sponges reveals anticancer activity and potential cell death via ferroptosis by mycalols","volume":"19","author":"Riccio","year":"2021","journal-title":"Mar. Drugs"},{"key":"B84","doi-asserted-by":"publisher","first-page":"8755","DOI":"10.1038\/ncomms9755","article-title":"MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment","volume":"6","author":"Riesenberg","year":"2015","journal-title":"Nat. Commun."},{"key":"B85","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/medsci9040063","article-title":"Epidemiology of melanoma","volume":"9","author":"Saginala","year":"2021","journal-title":"Med. Sci. (Basel, Switz."},{"key":"B86","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nrm2428","article-title":"A gene regulatory network orchestrates neural crest formation","volume":"9","author":"Sauka-Spengler","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40170-015-0138-0","article-title":"Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth","volume":"3","author":"Sch\u00f6ckel","year":"2015","journal-title":"Cancer Metab."},{"key":"B88","doi-asserted-by":"publisher","first-page":"102243","DOI":"10.1016\/j.nano.2020.102243","article-title":"Targeting non-apoptotic cell death in cancer treatment by nanomaterials: Recent advances and future outlook","volume":"29","author":"Sepand","year":"2020","journal-title":"Nanomedicine"},{"key":"B89","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/acscentsci.7b00589","article-title":"Resolving the role of lipoxygenases in the initiation and execution of ferroptosis","volume":"4","author":"Shah","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"868630","DOI":"10.3389\/fchem.2022.868630","article-title":"Multifunctional nanomaterials for ferroptotic cancer therapy","volume":"10","author":"Shi","year":"2022","journal-title":"Front. Chem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"114643","DOI":"10.1016\/j.addr.2022.114643","article-title":"Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors","volume":"192","author":"Sun","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1038\/s41467-018-04664-0","article-title":"Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy","volume":"9","author":"Talebi","year":"2018","journal-title":"Nat. Commun."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.21037\/tcr.2020.01.62","article-title":"Sorafenib sensitizes melanoma cells to vemurafenib through ferroptosis","volume":"9","author":"Tang","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"B94","first-page":"244","article-title":"Primary malignant melanoma of the meninges","volume":"7","author":"Thornton","year":"1988","journal-title":"Clin. Neuropathol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","article-title":"Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress","volume":"33","author":"Tsoi","year":"2018","journal-title":"Cancer Cell"},{"key":"B96","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.hoc.2009.03.010","article-title":"Melanoma epidemiology","volume":"23","author":"Tucker","year":"2009","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"B97","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2217\/mmt-2016-0018","article-title":"Surgical resection of metastatic melanoma in the era of immunotherapy and targeted therapy","volume":"4","author":"Tyrell","year":"2017","journal-title":"Melanoma Manag."},{"key":"B98","doi-asserted-by":"publisher","first-page":"102650","DOI":"10.1016\/j.redox.2023.102650","article-title":"Redox phospholipidomics discovers pro-ferroptotic death signals in A375 melanoma cells in vitro and in vivo","volume":"61","author":"Tyurina","year":"2023","journal-title":"Redox Biol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","article-title":"Lymph protects metastasizing melanoma cells from ferroptosis","volume":"585","author":"Ubellacker","year":"2020","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.3390\/nano11092324","article-title":"Light-activated protoporphyrin IX-based polysilsesquioxane nanoparticles induce ferroptosis in melanoma cells","volume":"11","author":"Vadarevu","year":"2021","journal-title":"Nanomater. (Basel)"},{"key":"B101","doi-asserted-by":"publisher","first-page":"927118","DOI":"10.3389\/fcell.2022.927118","article-title":"Targeting of the lipid metabolism impairs resistance to BRAF kinase inhibitor in melanoma","volume":"10","author":"Vergani","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.gendis.2022.04.004","article-title":"Melanoma: Molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance","volume":"9","author":"Wagstaff","year":"2022","journal-title":"Genes Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.7150\/thno.16141","article-title":"X-ray induced photodynamic therapy: A combination of radiotherapy and photodynamic therapy","volume":"6","author":"Wang","year":"2016","journal-title":"Theranostics"},{"key":"B105","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1038\/s41467-021-25990-w","article-title":"A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis","volume":"12","author":"Wang","year":"","journal-title":"Nat. Commun."},{"key":"B106","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.3390\/cells11223580","article-title":"Targeting wnt\/\u03b2-catenin signaling exacerbates ferroptosis and increases the efficacy of melanoma immunotherapy via the regulation of MITF","volume":"11","author":"Wang","year":"","journal-title":"Cells"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1039\/d2sc06675k","article-title":"A mitochondria-localized iridium(iii) photosensitizer for two-photon photodynamic immunotherapy against melanoma","volume":"14","author":"Wang","year":"","journal-title":"Chem. Sci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"113636","DOI":"10.1016\/j.biopha.2022.113636","article-title":"Gambogenic acid antagonizes the expression and effects of long non-coding RNA NEAT1 and triggers autophagy and ferroptosis in melanoma","volume":"154","author":"Wang","year":"","journal-title":"Biomed. Pharmacother."},{"key":"B109","doi-asserted-by":"publisher","first-page":"115110","DOI":"10.1016\/j.taap.2020.115110","article-title":"Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition","volume":"401","author":"Wang","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jid.2021.05.025","article-title":"CAMKK2 defines ferroptosis sensitivity of melanoma cells by regulating AMPK\u2012NRF2 pathway","volume":"142","author":"Wang","year":"","journal-title":"J. Invest. Dermatol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cell.2006.11.039","article-title":"NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN","volume":"128","author":"Wang","year":"2007","journal-title":"Cell"},{"key":"B112","doi-asserted-by":"publisher","first-page":"735965","DOI":"10.3389\/fphar.2021.735965","article-title":"Ferroptosis-inducing nanomedicine for cancer therapy","volume":"12","author":"Wang","year":"","journal-title":"Front. Pharmacol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"819235","DOI":"10.3389\/fonc.2022.819235","article-title":"PLA2G6 silencing suppresses melanoma progression and affects ferroptosis revealed by quantitative proteomics","volume":"12","author":"Wang","year":"","journal-title":"Front. Oncol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"","journal-title":"Drug resist. updat."},{"key":"B115","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.cell.2017.09.044","article-title":"PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals","volume":"171","author":"Wenzel","year":"2017","journal-title":"Cell"},{"key":"B116","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41568-019-0213-x","article-title":"Controversies around epithelial-mesenchymal plasticity in cancer metastasis","volume":"19","author":"Williams","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"B117","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.tcb.2017.11.006","article-title":"Exploiting metabolic vulnerabilities of cancer with precision and accuracy","volume":"28","author":"Wolpaw","year":"2018","journal-title":"Trends Cell Biol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"032003","DOI":"10.1088\/1748-605X\/abd0c4","article-title":"Therapeutic strategies of iron-based nanomaterials for cancer therapy","volume":"16","author":"Wu","year":"2021","journal-title":"Biomed. Mater"},{"key":"B119","doi-asserted-by":"publisher","first-page":"109235","DOI":"10.1016\/j.celrep.2021.109235","article-title":"The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity","volume":"35","author":"Xu","year":"2021","journal-title":"Cell Rep."},{"key":"B120","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1111\/jcmm.14511","article-title":"Molecular mechanisms of ferroptosis and its role in cancer therapy","volume":"23","author":"Xu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2020.11.024","article-title":"Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1","volume":"81","author":"Yan","year":"2021","journal-title":"Mol. Cell"},{"key":"B122","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial-mesenchymal transition","volume":"21","author":"Yang","year":"","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B124","doi-asserted-by":"publisher","first-page":"e2204365","DOI":"10.1002\/advs.202204365","article-title":"Emerging sonodynamic therapy-based nanomedicines for cancer immunotherapy","volume":"10","author":"Yang","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"B125","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41467-020-14324-x","article-title":"Nedd4 ubiquitylates VDAC2\/3 to suppress erastin-induced ferroptosis in melanoma","volume":"11","author":"Yang","year":"","journal-title":"Nat. Commun."},{"key":"B126","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3892\/ol.2021.12918","article-title":"Iron regulatory protein 1 promotes ferroptosis by sustaining cellular iron homeostasis in melanoma","volume":"22","author":"Yao","year":"2021","journal-title":"Oncol. Lett."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3724\/abbs.2022166","article-title":"Arginase 2 negatively regulates sorafenib-induced cell death by mediating ferroptosis in melanoma","volume":"54","author":"Yu","year":"2022","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"B128","doi-asserted-by":"publisher","first-page":"13953","DOI":"10.1002\/chem.202101514","article-title":"Chemodynamic therapy combined with multifunctional nanomaterials and their applications in tumor treatment","volume":"27","author":"Yu","year":"2021","journal-title":"Chemistry"},{"key":"B129","doi-asserted-by":"publisher","first-page":"817","DOI":"10.7150\/thno.67932","article-title":"Targeting regulated cell death in tumor nanomedicines","volume":"12","author":"Zeng","year":"2022","journal-title":"Theranostics"},{"key":"B130","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: A novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/mc.22878","article-title":"miR-9 regulates ferroptosis by targeting glutamic-oxaloacetic transaminase GOT1 in melanoma","volume":"57","author":"Zhang","year":"2018","journal-title":"Mol. Carcinog."},{"key":"B132","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1039\/d0nr08478f","article-title":"Nanoparticle-induced ferroptosis: Detection methods, mechanisms and applications","volume":"13","author":"Zheng","year":"2021","journal-title":"Nanoscale"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s11864-022-01006-7","article-title":"BRAF inhibitor resistance in melanoma: Mechanisms and alternative therapeutic strategies","volume":"23","author":"Zhong","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"112524","DOI":"10.1016\/j.msec.2021.112524","article-title":"Hierarchical dual-responsive cleavable nanosystem for synergetic photodynamic\/photothermal therapy against melanoma","volume":"131","author":"Zhong","year":"2021","journal-title":"Mater Sci. Eng. C Mater Biol. Appl."},{"key":"B135","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","article-title":"Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis","volume":"16","author":"Zou","year":"2020","journal-title":"Nat. Chem. Biol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1252567\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T04:34:48Z","timestamp":1695184488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1252567\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":135,"alternative-id":["10.3389\/fphar.2023.1252567"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1252567","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"article-number":"1252567"}}